NovAccess Financial Statements From 2010 to 2024
| XSNX Stock | USD 0.01 0 80.00% |
Check NovAccess Global financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NovAccess Global's main balance sheet or income statement drivers, such as , as well as many indicators such as . NovAccess financial statements analysis is a perfect complement when working with NovAccess Global Valuation or Volatility modules.
NovAccess |
NovAccess Global Company Price To Earning Analysis
NovAccess Global's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current NovAccess Global Price To Earning | 2.69 X |
Most of NovAccess Global's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, NovAccess Global is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Based on the latest financial disclosure, NovAccess Global has a Price To Earning of 2.69 times. This is 89.59% lower than that of the Healthcare sector and 45.44% lower than that of the Biotechnology industry. The price to earning for all United States stocks is 90.63% higher than that of the company.
NovAccess Global Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining NovAccess Global's current stock value. Our valuation model uses many indicators to compare NovAccess Global value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across NovAccess Global competition to find correlations between indicators driving NovAccess Global's intrinsic value. More Info.NovAccess Global is rated second in return on asset category among its peers. It is rated second in current valuation category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value NovAccess Global by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for NovAccess Global's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About NovAccess Global Financial Statements
NovAccess Global investors use historical fundamental indicators, such as NovAccess Global's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in NovAccess Global. Please read more on our technical analysis and fundamental analysis pages.
NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. NovAccess Global Inc. was incorporated in 1997 and is headquartered in Chesterland, Ohio. Novaccess Global operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 2 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for NovAccess Pink Sheet Analysis
When running NovAccess Global's price analysis, check to measure NovAccess Global's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NovAccess Global is operating at the current time. Most of NovAccess Global's value examination focuses on studying past and present price action to predict the probability of NovAccess Global's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NovAccess Global's price. Additionally, you may evaluate how the addition of NovAccess Global to your portfolios can decrease your overall portfolio volatility.